Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H25FN6O3 |
| Molecular Weight | 428.46 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNC(=O)NC1=NC2=CC(C3=CN=C(N=C3)C(C)(C)O)=C(F)C([C@H]4CCCO4)=C2N1
InChI
InChIKey=BKUISYCLLXCBJV-CQSZACIVSA-N
InChI=1S/C21H25FN6O3/c1-4-23-20(29)28-19-26-13-8-12(11-9-24-18(25-10-11)21(2,3)30)16(22)15(17(13)27-19)14-6-5-7-31-14/h8-10,14,30H,4-7H2,1-3H3,(H3,23,26,27,28,29)/t14-/m1/s1
| Molecular Formula | C21H25FN6O3 |
| Molecular Weight | 428.46 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 04:53:54 GMT 2025
by
admin
on
Wed Apr 02 04:53:54 GMT 2025
|
| Record UNII |
0O34AIS1YE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000039064
Created by
admin on Wed Apr 02 04:53:54 GMT 2025 , Edited by admin on Wed Apr 02 04:53:54 GMT 2025
|
PRIMARY | |||
|
57524959
Created by
admin on Wed Apr 02 04:53:54 GMT 2025 , Edited by admin on Wed Apr 02 04:53:54 GMT 2025
|
PRIMARY | |||
|
1384984-18-2
Created by
admin on Wed Apr 02 04:53:54 GMT 2025 , Edited by admin on Wed Apr 02 04:53:54 GMT 2025
|
PRIMARY | |||
|
0O34AIS1YE
Created by
admin on Wed Apr 02 04:53:54 GMT 2025 , Edited by admin on Wed Apr 02 04:53:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
SPR719 showed potent activity against MAC (MIC90, 2?mg/liter) and M. kansasii (MIC90, 0.125?mg/liter) and modest activity against M. abscessus (MIC90, 8?mg/liter); its activity is bacteriostatic and concentration-dependent.
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
SPR719 showed potent activity against MAC (MIC90, 2?mg/liter) and M. kansasii (MIC90, 0.125?mg/liter) and modest activity against M. abscessus (MIC90, 8?mg/liter); its activity is bacteriostatic and concentration-dependent.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
